These sources provide a comprehensive analysis of colour vision deficiency (CVD), examining its genetic foundations, diagnostic methods, and emerging treatments. Research highlights how conditions like achromatopsia and blue cone monochromacy arise from specific gene mutations that alter retinal structures, often resulting in reduced nerve layer thickness. Beyond congenital causes, the texts explore acquired deficits triggered by medications, toxic solvents, or chronic illnesses such as diabetes. Diagnostic tools, including the Ishihara and Farnsworth-Munsell tests, are evaluated alongside modern technologies like gene therapy and AI-driven image enhancement. Furthermore, the collection addresses the societal impact of CVD, offering guidance on digital accessibility, workplace accommodations, and the occupational standards required for visually demanding roles.